Table 2 GRADE summary.

From: A systematic review of non-surgical management in Peyronieʼs disease

Non-surgical treatment

Evidence for improvement? (GRADE level of evidence)

Penile curvature

Plaque size

Pain

IIEF

Penile length

Oral

Vitamin E

Yes (Moderate)

Yes (Moderate)

No (Moderate)

Yes (Moderate)

N/A

Tamoxifen

No (Very Low)

No (Low)

No (Very Low)

N/A

N/A

POTABA

Yes (Low)

Yes (Low)

N (Very Low)

N/A

N/A

PDEi-5

No (Low)

No (Very Low)

Yes (Low)

Yes (Low)

N/A

Colchicine

No (Low)

No (Very Low)

No (Very Low)

N/A

N/A

Carnitine

Yes (Very Low)

Yes (Very Low)

No (Very Low)

No (Low)

N/A

Co-Enzyme Q10

Yes (Low)

Yes (Low)

No (Low)

Yes (Low)

N/A

Intralesional

Intralesional CCH

Yes (Moderate)

N/A

No (Moderate)

Yes (Low)

Yes (Low)

Interferon

Yes (Very Low)

Yes (Low)

Yes (Low)

No (Low)

N/A

Intralesional CCB

No (Low)

Yes (Low)

Yes (Low)

Yes (Low)

N/A

HA

Yes (Low)

No (Very Low)

N/A

No (Very Low)

N/A

Intralesional thiocolchicine

Yes (Low)

No (Low)

N/A

No (Low)

N/A

Topical

ESWT

Yes (Low)

Yes (Moderate)

Yes (Low)

Yes (Moderate)

No (Low)

Electromotive

Yes (Moderate)

Yes (Moderate)

Yes (Moderate)

No (Moderate)

No (Moderate)

Traction device

Yes (Moderate)

N/A

No (Moderate)

No (Moderate)

Yes (Moderate)

Laser

Yes (Moderate)

No (Moderate)

Yes (Moderate)

Yes (Moderate)

No (Moderate)

Topical therapy

No (Low)

Yes (Low)

Yes (Low)

N/A

Yes (Low)

  1. Key for Table 2.
  2. CCH collagenase clostridium histolyticum, CCB calcium channel blocker, ESWT extracorporeal shockwave therapy, PDEi-5 phosphodiesterase type 5 (PDE5) inhibitors, HA hyaluronic acid.